Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207. [electronic resource]
Producer: 19990630Description: 2608-15 p. digitalISSN:- 0008-543X
- Animals
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- chemistry
- Doxorubicin -- analogs & derivatives
- Female
- Gonadotropin-Releasing Hormone -- analogs & derivatives
- Humans
- Male
- Mice
- Mice, Nude
- Neoplasm Transplantation
- RNA, Messenger -- biosynthesis
- Receptors, LHRH -- drug effects
- Transplantation, Heterologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.